STOCK TITAN

PetMed Express, Inc. Sets Third Quarter 2022 Earnings Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

PetMed Express (PETS) has announced a conference call scheduled for February 6, 2023, at 4:30 PM Eastern Time to discuss its third-quarter financial results for the period ending December 31, 2022. This call will be preceded by a press release detailing the financial results. Interested parties can join via a U.S. dial-in number or international line, and a replay will be available until February 20, 2023. PetMed Express, founded in 1996, provides prescription and non-prescription medications for pets through its 1-800-PetMeds service and website. Key risks and uncertainties, including the company's ability to fulfill its business objectives, are noted in their SEC filings.

Positive
  • Upcoming conference call for Q3 results may enhance investor transparency.
  • Replay availability extends access to financial data until February 20, 2023.
Negative
  • Risks associated with achieving business plan objectives highlighted in forward-looking statements.
  • Dependence on SEC filings for understanding operational risks.

DELRAY BEACH, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the “Company”), Your Trusted Pet Health Expert™ will hold a conference call on Monday, February 6, 2023 at 4:30pm Eastern time to discuss its financial results for the third quarter ended December 31, 2022. Financial results will be issued in a press release prior to the call.

PetMed management will host the conference call, followed by a question and answer period.

Date: Monday, February 6, 2023
Time: 4:30pm Eastern time (1:30pm Pacific time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: PetMeds Q3 Earnings Webcast

Please call the conference telephone number 5-10 minutes prior to the start time. If you have any difficulty connecting with the conference call, please contact MZ Group at 561-374-0177.

A telephonic replay of the conference call will also be available after 7:30 PM Eastern time on the same day through February 20, 2023.

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13735907

About PetMed Express

Founded in 1996, PetMeds is Your Trusted Pet Health Expert™, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at www.petmeds.com.

Forward-Looking Statements
This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2022. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

Investor Contact:
MZ North America
Brian M. Prenoveau, CFA
investor@petmeds.com
(561) 374-0177


FAQ

When will PetMed Express announce its Q3 2023 financial results?

PetMed Express will announce its Q3 2023 financial results on February 6, 2023.

What time is the PetMed Express conference call for Q3 results?

The conference call for Q3 results is scheduled for 4:30 PM Eastern Time on February 6, 2023.

How can I listen to the PetMed Express Q3 earnings call?

You can listen to the PetMed Express Q3 earnings call via a U.S. dial-in number or an international number provided in the press release.

What risks are associated with PetMed Express according to the press release?

The press release mentions risks related to the company's ability to meet its business objectives, as outlined in its SEC filings.

PetMed Express, Inc.

NASDAQ:PETS

PETS Rankings

PETS Latest News

PETS Stock Data

107.35M
20.66M
8.1%
59.27%
9.77%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States of America
DELRAY BEACH